Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality DOI Open Access
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

et al.

European Neuropsychopharmacology, Journal Year: 2023, Volume and Issue: 78, P. 1 - 2

Published: Oct. 19, 2023

Language: Английский

Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study DOI
Vardan Nersesjan,

Rune Haubo Bojesen Christensen,

Elisabeth Andersen

et al.

The Lancet Psychiatry, Journal Year: 2024, Volume and Issue: 11(10), P. 796 - 806

Published: Sept. 3, 2024

Language: Английский

Citations

5
Lithium and the risk of severe COVID-19 infection: A retrospective population-based register study DOI Creative Commons
Niklas Nilsson, Marie Bendix, Louise Öhlund

et al.

Journal of Psychosomatic Research, Journal Year: 2025, Volume and Issue: 190, P. 112053 - 112053

Published: Feb. 13, 2025

Language: Английский

Citations

0
Psychopharmacotherapy factor in the variants of COVID-19 course in psychiatric inpatients DOI Creative Commons
Н. Г. Незнанов, О. В. Лиманкин, A. V. Shabelnik

et al.

V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, Journal Year: 2024, Volume and Issue: 58(2), P. 79 - 88

Published: April 25, 2024

The aim of this study is to examine the relationship between severity and duration criteria COVID-19 psychopharmacotherapy administered patients in within a psychiatric hospital. Materials Methods. We analyzed 169 case histories involving completed clinical cases treatment specialized infectious department St. Petersburg, covering period from May 2020 January 2021. Correlation, dispersion, regression analyses were employed evaluate severe mild progression indicators, as well persistent SARS-CoV-2 viral shedding. assessed laboratory parameters patients, along with administered, including antidepressants, antipsychotics, acid sphingomyelinase inhibitors (FIASMA-active drugs). Results. Cardiovascular diseases emerged predictor when combined an increasing platelet-to-lymphocyte ratio (PLR), risk course by over two-fold. use any psychotropic agents was associated 0.9% increase for each unit systemic inflammation index PLR, specifically intellectual disability (ICD-10 codes F70-79), compared schizophrenia F20-29). High PLR values FIASMA-active drugs prolonged duration, while antidepressant therapy elevated C-reactive protein levels reduced predicted shedding 13.8% variance. Additional consideration nosology disorders model increased proportion explained variance 22.8%. Conclusion. Consideration should be given thymoanaleptic individuals during periods disease incidence leading up potential infection, it may serve protective factor against COVID-19. Furthermore, there no evidence suggest adverse effects antipsychotics on Further research required investigate psychopharmacological nosologically homogeneous groups.

Language: Английский

Citations

1
Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality DOI Open Access
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

et al.

European Neuropsychopharmacology, Journal Year: 2023, Volume and Issue: 78, P. 1 - 2

Published: Oct. 19, 2023

Language: Английский

Citations

0